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Abstract 
Background: Cancer, a major cause of mortality worldwide, is a group of diseases distinguished by uncontrolled 
growth and expansion of abnormal cells. According to American Cancer Society, melanoma, a kind of skin cancer, is 
one of the most prevalent cancers. The side effects of chemical treatment developed more demands on natural 
products. Flavonoids, polyphenol compounds, with anticancer and antioxidant activity attracted more attention to 
themselves. 
Materials and Methods: Through this investigation the effect of myricetin on cell proliferation was determined by 
MTT (Methylthiazolyl diphenyl-tetrazolium bromide) assay. A375 cell lines were seeded in a 96 wells plate and were 
exposed to different concentrations of myricetin (10, 15, 20, 40, 60, 80, and 100µΜ). After considered times, the 
MTT solution was added, then the viability of cells was detected by measuring the absorbance on 570 and 630 nm. 
Results: Our finding showed that low concentration of myricetin (up to 25µM) has no toxicity effect. Also the 
result confirmed the IC50 of myricetin on melanoma cells for three ordered period (24, 48, 72 hours) as following: 
50, 40, 35µΜ, respectively. 
Conclusion: According to this research, myricetin has anti-proliferative effect on melanoma cells, which can be used 
as a therapeutic agent. We hope that this study could be used as a mile stone in future researches to acquire 
confirmative results. 
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Introduction 
Cancer as a leading cause of death in most countries, 
especially in less developed countries is growing 
worldwide. The approval of mechanical lifestyle, poor 
diet, less activity, smoking and reproductive changes 
have increased the cancer burden globally
1
. Among the 
list of common cancers reported by the American Cancer 
Society, melanoma, a kind of skin cancer, due to new 
lifestyles allocated high rate of mortality to itself
2
. 
The toxicity of current chemotherapeutics put all of 
efforts toward new anticancer drugs with greater efficacy 
and fewer side effects. Among natural compounds, low 
molecular weight product, flavonoids, rich in seeds, 
vegetables, and citrus fruits, attracted more attention 
according to their impressive pharmacological properties 
including antibacterial, antioxidant, antiangiogenic, 
anticancer and antiallergic activities
3
.  
Chemically they are polyphenol with a phenyl 
benzopyrone structure (C6- C3-C6), on the basis of 
